Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.
Banked acute-phase and convalescent-phase serum samples from a previous study of respiratory illness in university students were examined for significant (>/=2-fold) increases in ELISA titers of IgA and IgG antibody to Bordetella pertussis filamentous hemagglutinin, pertactin, and fimbriae-2 and >/=4-fold titer increases to agglutinogens by agglutination. ELISA titers of antibody to pertussis toxin could not be determined because of technical problems. Chlamydia pneumoniae infections were diagnosed by culture or by a >/=4-fold increase in immunofluorescence assay titer or a single high titer (>/=512). Mycoplasma pneumoniae, influenza A and B, adenovirus, and respiratory syncytial virus infections were diagnosed by >/=4-fold increases in complement fixation titer or a single high titer (>/=64). There were 319 subjects with cough of >/=5 days' duration, and of these, 47 (15%) had significant increases in antibody to B. pertussis antigens; 26 (8%) had significant increases to fimbriae-2 or agglutinogens, indicative of B. pertussis infection, and 2 (1%) had evidence of non-B. pertussis bordetella infections. Seventeen (36%) had evidence of mixed infections or cross-reacting antibodies (influenza B infections, 5; adenovirus infections, 4; influenza A infections, 3; C. pneumoniae infections, 3; and M. pneumoniae infections, 2). Our findings suggest that bordetella infections are common in young adults with cough illnesses (incidence, 9%), and a surprising number of these are mixed infections with other respiratory pathogens.
Jackson
L A
LA
School of Public Health and Community Medicine, Dept. of Epidemiology, University of Washington, Seattle, WA, 98195, USA. lajack@u.washington.edu
Cherry
J D
JD
Wang
S P
SP
Grayston
J T
JT
D000258:Adenovirus Infections, Human / Q000097:blood / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D000260:Adenoviruses, Human / Q000276:immunology; D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001886:Bordetella pertussis / Q000276:immunology; D002690:Chlamydia Infections / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D016993:Chlamydophila pneumoniae / Q000276:immunology; D003371:Cough / Q000097:blood / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007251:Influenza, Human / Q000097:blood / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D009177:Mycoplasma pneumoniae / Q000276:immunology; D011019:Pneumonia, Mycoplasma / Q000097:blood / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D012141:Respiratory Tract Infections / Q000150:complications / Q000382:microbiology / Q000821:virology; D013334:Students; D014495:Universities; D014917:Whooping Cough / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000276:immunology
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral